Aspiriant, LLC Bristol Myers Squibb CO Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aspiriant, LLC holds 8,092 shares of BMY stock, worth $430,413. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,092

Previous 6,789 19.19%

Holding current value

$430,413

Previous $281,000 48.75%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$39.66 - $51.75 $51,676 - $67,430	1,303 Added 19.19%	8,092 $418,000
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $93,742 - $123,413	-2,329 Reduced 25.54%	6,789 $281,000
Q1 2024 Apr 15, 2024	BUY	$47.98 - $54.4 $33,681 - $38,188	702 Added 8.34%	9,118 $494,000
Q4 2023 Jan 26, 2024	BUY	$48.48 - $57.85 $41,159 - $49,114	849 Added 11.22%	8,416 $431,000
Q3 2023 Oct 17, 2023	SELL	$57.89 - $64.73 $350,466 - $391,875	-6,054 Reduced 44.45%	7,567 $439,000
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $46,890 - $52,064	-736 Reduced 5.13%	13,621 $871,000
Q1 2023 Apr 27, 2023	SELL	$65.71 - $74.53 $3,285 - $3,726	-50 Reduced 0.35%	14,357 $995,000
Q4 2022 Jan 23, 2023	BUY	$68.48 - $81.09 $95,050 - $112,552	1,388 Added 10.66%	14,407 $0
Q3 2022 Oct 28, 2022	BUY	$0.13 - $76.84 $14 - $8,529	111 Added 0.86%	13,019 $925,000
Q2 2022 Jul 25, 2022	BUY	$72.62 - $79.98 $196,582 - $216,505	2,707 Added 26.54%	12,908 $995,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $115,643 - $138,667	-1,881 Reduced 15.57%	10,201 $745,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $237,259 - $276,588	4,424 Added 57.77%	12,082 $753,000
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $7,396 - $8,663	-125 Reduced 1.61%	7,658 $453,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $4,271 - $4,651	69 Added 0.89%	7,783 $519,000
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $52,812 - $59,398	890 Added 13.04%	7,714 $487,000
Q4 2020 Feb 01, 2021	BUY	$57.74 - $65.43 $21,479 - $24,339	372 Added 5.77%	6,824 $422,000
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $1,665 - $1,845	29 Added 0.45%	6,452 $390,000
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $21,599 - $25,251	-394 Reduced 5.78%	6,423 $377,000
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $464 - $674	-10 Reduced 0.15%	6,817 $381,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $35,628 - $46,473	724 Added 11.86%	6,827 $440,000
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $13,985 - $16,582	-327 Reduced 5.09%	6,103 $312,000
Q2 2019 Aug 06, 2019	SELL	$44.62 - $49.34 $71,704 - $79,289	-1,607 Reduced 20.0%	6,430 $291,000
Q1 2019 May 03, 2019	SELL	$45.12 - $53.8 $24,409 - $29,105	-541 Reduced 6.31%	8,037 $382,000
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $57,341 - $74,358	-1,176 Reduced 12.06%	8,578 $447,000
Q3 2018 Oct 26, 2018	SELL	$55.19 - $62.25 $259,061 - $292,201	-4,694 Reduced 32.49%	9,754 $605,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $345,877 - $431,098	-6,845 Reduced 32.15%	14,448 $800,000
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $1.28 Million - $1.47 Million	21,293 New	21,293 $1.35 Million
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $919,479 - $1 Million	-15,340 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $847,228 - $977,771	15,340	15,340 $978,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account